Abstract
BackgroundPlants produce a variety of specialized metabolites, many of which are used in pharmaceutical industries as raw materials. However, certain metabolites may be produced at markedly low concentrations in plants. This problem has been overcome through metabolic engineering in recent years, and the production of valuable plant compounds using microorganisms such as Escherichia coli or yeast cells has been realized. However, the development of complicated pathways in a single cell remains challenging. Additionally, microbial cells may experience toxicity from the bioactive compounds produced or negative feedback effects exerted on their biosynthetic enzymes. Thus, co-culture systems, such as those of E. coli–E. coli and E. coli-Saccharomyces cerevisiae, have been developed, and increased production of certain compounds has been achieved. Recently, a co-culture system of Pichia pastoris (Komagataella phaffii) has gained considerable attention due to its potential utility in increased production of valuable compounds. However, its co-culture with other organisms such as E. coli, which produce important intermediates at high concentrations, has not been reported.ResultsHere, we present a novel co-culture platform for E. coli and P. pastoris. Upstream E. coli cells produced reticuline from a simple carbon source, and the downstream P. pastoris cells produced stylopine from reticuline. We investigated the effect of four media commonly used for growth and production of P. pastoris, and found that buffered methanol-complex medium (BMMY) was suitable for P. pastoris cells. Reticuline-producing E. coli cells also showed better growth and reticuline production in BMMY medium than that in LB medium. De novo production of the final product, stylopine from a simple carbon source, glycerol, was successful upon co-culture of both strains in BMMY medium. Further analysis of the initial inoculation ratio showed that a higher ratio of E. coli cells compared to P. pastoris cells led to higher production of stylopine.ConclusionsThis is the first report of co-culture system established with engineered E. coli and P. pastoris for the de novo production of valuable compounds. The co-culture system established herein would be useful for increased production of heterologous biosynthesis of complex specialized plant metabolites.
Highlights
Plants produce a variety of specialized metabolites, many of which are used in pharmaceutical industries as raw materials
Considering that the efficient recovery of end-product was possible from the medium, without the extraction from cells, we considered the BMMY medium to be more appropriate for stylopine production and used this medium for further analysis
Reticuline production using E. coli in the BMMY medium we examined the effect of MeOH, which was added to the BMMY medium to induce protein expression in P. pastoris, on the growth and reticuline production in reticuline-producing E. coli cells
Summary
Plants produce a variety of specialized metabolites, many of which are used in pharmaceutical industries as raw materials. Certain metabolites may be produced at markedly low concentrations in plants This problem has been overcome through metabolic engineering in recent years, and the production of valuable plant compounds using microorganisms such as Escherichia coli or yeast cells has been realized. Owing to the decrease in plant resources and their low concentrations in plant cells, the stable supply of some such compounds may be challenging in the future To solve these problems, biosynthetic enzymes have been investigated, with their corresponding genes identified and isolated. Metabolic engineering, a process in which genes for biosynthetic enzymes are introduced into microorganisms such as Escherichia coli or Saccharomyces cerevisiae, leading to successful production of valuable compounds has been reported [2, 3]. Few examples are as follows: the production of thebaine, an important opiate, by E. coli [4] and S. cerevisiae [5]; the production of tropane alkaloids, that act as neurotransmitter inhibitors, by S. cerevisiae [6]; and the production of resveratrol, a stilbene with potential health-promoting benefits, by E. coli and S. cerevisiae [7]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.